Volume 8, Issue 3, May 2020, Page: 67-70
To Determine the Incidence and Risk Factors Associated with Placenta Previa in a Tertiary Care Hospital of Pakistan
Sadia Asghar, Department of Obstetrics and Gynecology, Naizi Medical College, Sargodha, Pakistan
Samra Asghar Cheema, Department of Obstetrics and Gynecology, Sir Ganga Ram Hospital, Lahore, Pakistan
Nafeesa Naz, Department of Obstetrics and Gynecology, Allied Hospital, Faisalabad, Pakistan
Received: Mar. 9, 2020;       Accepted: Apr. 21, 2020;       Published: May 28, 2020
DOI: 10.11648/j.jgo.20200803.14      View  65      Downloads  30
Abstract
Placenta previa is the condition of pregnancy in which placenta implants in lower uterine segment, partially or completely covering the internal os. This condition may associate with many risk factors. Because with placenta previa pregnancy becomes high risk and fetomaternal morbidities and mortalities are also increased. By knowing the risk factors which are the main causative factors for placenta previa fetomaternal outcome can be optimized The purpose of this study is to find the incidence of placenta previa, and also determine the risk factors for placenta previa. This is descriptive prospective study. This study was done in tertiary care hospital of Pakistan. In this study total deliveries were 5381, total patient with previa were found 325 (6.03%). The risk factors of placenta previa are age more than 35 years (28.92%), smoking (20.16%), multiparity (44%), uterine scar (60.30%), previous evacuation and curettage (24.30%). According to age distribution to mostly patients about 135 out of 325 were found between age group of 36-40 years with percentage of 41.23%. Distribution of patients accrding to gestational age mostly found between age 33-35 weeks with percentage of 54.76 percent amd according to gravidity mostly found between G5–G7 with percentage of 42.46 percent. Aim of the study is to find out the risk factors associated with placenta previa and also determine the incidence of placenta previa in tertiary care hospital of Pakistan.
Keywords
Fetomaternal, Morbidities, Mortalities
To cite this article
Sadia Asghar, Samra Asghar Cheema, Nafeesa Naz, To Determine the Incidence and Risk Factors Associated with Placenta Previa in a Tertiary Care Hospital of Pakistan, Journal of Gynecology and Obstetrics. Vol. 8, No. 3, 2020, pp. 67-70. doi: 10.11648/j.jgo.20200803.14
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Oyelese Y, Sumalian JC. Placenta previa, Placenta accrete and Vasa Previa. Obstet Gynecol 2006; 107: 927-41.
[2]
L. Latif, U. J. Iqbal, and M. U. Aftab, “Associated risk Factors of placenta Previa a matched case control study,”Pakistan Journal of Medical and Health Science, Vol. 9, nou, pp. 1344-1346, 2015.
[3]
J. A. Cresswel l, C. Ronnsmans, C. Calvert, and V. Fillipi”, Prevelance of placenta previa by world region: a systematic review and mata analysis. Tropical medicine and international Health, vol. 18, No. 6, PP. 712 724, 2013 view at publisher view at Google scholar. view at scopus.
[4]
Obstetric hemorrhage is a leading cause of fetometernal morbidity and mortality.
[5]
ACOG. Placenta accrete, Committee Opinion 2012; 529: re-affirmed 2015.
[6]
Wu. S, Koch erinsky M, Hibbard JU. Abonormal Placentation: twenty–year nalysis. Am J Obstet Gynecol 2005; 192: 14458-61.
[7]
Faiz AS. Ananth CV. Etiology and risk for placenta previa and overview and meta analysis of observational studies. J Matern Fetal Neonatal Med 2003; 13: 175-90.
[8]
Jaunioun E, Collins S, Burton GJ. Placenta accrete spectrum pathophysiology & evidence based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 2017; 17: 30731-30737.
[9]
Nirma ala CH, Mounisha NV, Placenta previa_ a study on maternal perinatal outcome ISOR Journal of Dental and medical science (IOSR-JDMS). 2017; 04 (7): 4-7.
[10]
Meenakshi Devarmani, Patil Sanjana, Tallur. placenta previa: maternal and foetal outcome. J Evol Med Dent Sci 2016; 5 (40): 2477-80.
[11]
Getahun D, Oyelss Y, Salihu HM, Anantha CV. Previous cesarean section delivery and risk of placenta previa and placenta abruption. Obstet Gynecol. 2006. Apr; 107 (4): 771-778.
[12]
Odibo AO, Chahilla AG, Stamilio DM, Stevens EJ, Peipert JF, Macones GA. Predicting placental abruption and placenta previa in women ith pevious cesarean delivery Am J Perinatal. 20076 May; 24 (5): 299-305.
[13]
Shreyasi S, Chanchal S, Sohani V, et al. Prenatal diagnosis &management of morbidly adherent placenta. J Clin Diagn Res. 2017; 11: 1-2.
[14]
Chaudhari HK, Shah PK, D’Souza N. Morbidly adherent placenta: its management & maternal & perinatal outcome. J Obstet Gynecol India 2017; 67: 42-47.
[15]
Tikkanen M, Stefanovic V, Paavonen J. Placenta previa percreta left in situ-management by delayed hysterectomy: a case report. Journal of Medical Case Reports 2011: 5: 418-421.
[16]
Ananth CV, Demissie K, Smulian JC, Vintzileos AM. Relationship among placenta previa, fetal growth restriction, and preterm delivery: A population based study. Obstet Gynecol. 2001; 98 (2): 299–306. doi: 10.1016/S0029-7844(01)01413-2.
[17]
Brace V, Kernaghan D, Penney G. Learning from adverse clinical outcomes: major obstetric haemorrhage in Scotland, 2003-05. BJOG. 2007; 114 (11): 1388–1396. doi: 10.1111/j.1471-0528.2007.01533.x.
[18]
Crane JMG, Van den Hof MC, Dodds L, Armson BA, Liston R. Maternal complications with placenta previa. Am J Perinatol. 2000; 17 (2): 101–105. doi: 10.1055/s-2000-9269.
[19]
Bhide A, Prefumo F, Moore J, Hollis B, Thilaganathan B. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. BJOG. 2003; 110 (9): 860–864. doi: 10.1111/j.1471-0528.2003.02491.x.
[20]
Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP. First-birth cesarean and placental abruption or previa at second birth. Obstet Gynecol. 2001; 97 (5): 765–769. doi: 10.1016/S0029-7844(01)01121-8.
[21]
HESOnline. 2011. http: //www.hesonline.nhs.uk/.
[22]
Ananth CV, Smulian JC, Vintzileos AM. The association of placenta previa with history of cesarean delivery and abortion: A metaanalysis. Am J Obstet Gynecol. 1997; 177 (5): 1071–1078. doi: 10.1016/S0002-9378(97)70017-6.
[23]
Thia EW, Tan LK, Devendra K, et al. Lessons learnt from to women with morbidly adherent placentas and a reviews of literature. Ann Acad Med Singapore 2007; 36; 298-303.
[24]
Kamara M, Kamara JJ, Henderson DA, et al. The risk of placenta accreta following primary elective caeseran delivery: a case control study. BJOG 2013; 120; 879-886.
[25]
Fitzpatrick KE, Sellers S, Spark P, et al. The management and outcomes of placenta accrete, increta and percreta in the UK: a population based descriptive study. BTOG 2014; 121: 62-71.
[26]
Society for Maternal fetal medicine. Clinical opinion. Placenta accreta AJOG 2010; 116: 431-439.
[27]
Loto, Onile TG. Placenta previa at the obafemi A Wolow University teaching Hospitals Complex, 11e–1fe. A ten years analysis. Niger J Clin Pract. 2008 Jun; 11 (2): 130–3.
[28]
Lala ABH, Rutherford JM. Massive or recurrent ante partum haemorrhage. Current Obstetrics and Gynaecology. 2002; 12: 226–230.
[29]
Eniola AO, Bako AU, Selo-Ojeme DO. Risk factors for placenta praevia in southern Nigeria. East Afr Med J. 2002; 79: 535–538.
Browse journals by subject